Aikang Health and Yitu Healthcare Partner to Advance AI-Driven Preventive Health Screening

VCBeat (WeChat ID: vcbeat) has learned that on November 20, iKang Group held a strategic upgrade conference in Beijing. A series of transformative initiatives were unveiled, including “Physical Examination 2.0 with Human Oversight,” the iKangAI+ plan, and the iKangNetwork+ plan. “Embracing AI, Exploring AI” emerged as the central theme.

As iKang Group’s AI partner, Yitu Healthcare CEO Ni Hao was invited to attend the conference and deliver a speech. In the future, both parties will engage in substantive cooperation in the areas of monitoring children’s growth and development, as well as screening physical examinations for multiple high-incidence cancers.

With the rapid development and advancement of medical artificial intelligence (AI) technology, the health checkup industry has keenly recognized that medical AI is becoming a valuable assistant and “second brain” for healthcare providers. It plays a significant role in improving the efficiency of cancer screening, reducing misdiagnoses and missed diagnoses, unlocking data potential, and expanding application scenarios, thereby emerging as an essential productivity tool for the upgrade of the health checkup industry in the new era.

Zhang Ligang, Founder, Chairman, and CEO of iKang Group, stated that the “Managed” Physical Examination 2.0 strategy aims to empower traditional health screenings with artificial intelligence, applying more innovative technologies throughout the entire health management process to help users achieve earlier detection, diagnosis, and treatment. Meanwhile, in response to the national “Healthy China 2030” call for “shared development and universal health,” iKang will collaborate with over 300 public hospitals across China to establish a Medical Consortium Alliance for physical examinations, thereby strengthening one-stop health management services.

As a leading domestic medical artificial intelligence enterprise, Yitu Healthcare boasts a portfolio of medical AI products that are at the forefront in China, along with extensive experience in AI implementation. Its subsidiaries includecare.ai™ Series AI applications cover multiple fields, including intelligent imaging, intelligent medical big data, and internet-based pediatrics. They have been implemented in hundreds of Grade 3A hospitals across China and have achieved coverage of county- and city-level regional medical centers in certain provinces and municipalities.

Previously, Yitu Healthcare launched the “AI Cancer Prevention Map” initiative, covering 19 provinces, municipalities, and autonomous regions as well as hundreds of medical institutions. This program leverages AI applications to empower early cancer screening, expanding the use cases of medical AI from healthcare facilities to the broader field of health management, thereby ushering China’s public health management into the “AI+” era.

Yitu Healthcare CEO Ni Hao stated that Yitu Healthcare currently focuses primarily on three major areas: intelligent diagnosis and treatment for oncology, cardiovascular and cerebrovascular diseases, and pediatrics. The company has already launched the AI Cancer Prevention Map project, aiming to empower health checkups with its intelligent oncology diagnosis and treatment system. He believes that artificial intelligence holds significant promise in health checkups and subsequent diagnostic and therapeutic fields.